Investing.com - Myovant Sciences (NYSE:MYOV) reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Myovant Sciences announced earnings per share of $-0.47 on revenue of $104.80. Analysts polled by Investing.com anticipated EPS of $-0.48 on revenue of $93.73M.
Myovant Sciences shares are up 71.61% from the beginning of the year, still down 0.45% from its 52 week high of $26.84 set on October 24.
Myovant Sciences follows other major Healthcare sector earnings this month
Myovant Sciences's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar